Comparison of the Vocal Cord Imaging Techniques After Thyroidectomy

September 10, 2017 updated by: DILEK YAZICIOGLU, Diskapi Teaching and Research Hospital
Recurrent nerve palsy is a complication of thyroidectomy. Most surgeons want to visualize the vocal cords after tyroidectomy. The aim is to compare the direct laringoscopy, videolaringoscopy, fiberoptic laringoscopy and ultrasonography methods in terms of efficacy, duration and hemodynamic responses during the procedure.

Study Overview

Detailed Description

The vocal cord will be visualised after the extubation with one of the following methods:

direct laringoscopy videolaringoscopy fiberoptic laringoscopy ultrasonography The of efficacy of the method (0= not able to visualize the vocal cords, 1= the vocal cords were visualized) duration of the procedure and hemodynamic responses (heart rate, mean arterial pressure) during the procedure will be compared between the groups.

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ankara, Turkey, 06110
        • Diskapi Yildirim Beyazit Teaching and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Benign or malignant thyroid pathology

Exclusion Criteria:

  • anticipated difficult intubation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: fiberoptic nasal laringoscopy
the vocal cords ill be visualized with fiberoptic nasal laringoscopy
the vocal cords will be visualized after extubation with fiberoptic nasal laringoscopy
Other Names:
  • fiberoptic laryngoscopy
Experimental: ultrasonography
the vocal cords ill be visualized with ultrasonography
the vocal cords will be visualized after extubation with fiberoptic ultrasonography
Other Names:
  • ultrsonography
Active Comparator: Direct laringoscopy
the vocal cords ill be visualized with direct laringoscopy
the vocal cords will be visualized after extubation with direct laringoscopy
Other Names:
  • direct laryngoscopy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
visualisation of the vocal cords
Time Frame: 1 min after extubation
the vocal cords will be examined after extubation
1 min after extubation
duration of the procedure
Time Frame: 10 min after extubation
the duration of the vocal cord examination
10 min after extubation
mean arterial pressure
Time Frame: 10 min after extubation
the mean arterial pressure will be measured after extubation
10 min after extubation
heart rate
Time Frame: 10 min after extubation
the heart rate will be measured after extubation
10 min after extubation
peripheal oxygen saturation
Time Frame: 10 min after extubation
the peripheal oxygen saturation will be measured after extubation
10 min after extubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
hypertention
Time Frame: 5 minutes after the extubation
mean arterial pressure >20% from baseline value
5 minutes after the extubation
tachycardia
Time Frame: 5 minutes after the extubation
heart rate >20% from baseline value
5 minutes after the extubation
laceration
Time Frame: 5 minutes after the extubation
blood detected on the blade/fiber optic scope, or macroscopic blood on the oral nasal mucosa
5 minutes after the extubation
teeht damage
Time Frame: 5 minutes after the extubation
broken teeht
5 minutes after the extubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Dilek yazicioglu, Dr, Diskapi Teaching and Research Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2015

Primary Completion (Actual)

June 1, 2015

Study Completion (Actual)

July 1, 2015

Study Registration Dates

First Submitted

February 14, 2015

First Submitted That Met QC Criteria

April 2, 2015

First Posted (Estimate)

April 8, 2015

Study Record Updates

Last Update Posted (Actual)

September 12, 2017

Last Update Submitted That Met QC Criteria

September 10, 2017

Last Verified

February 1, 2015

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Thyroid Nodule

Clinical Trials on fiberoptic nasal laringoscopy

Subscribe